Skip header and navigation

Narrow By

23 records – page 1 of 2.

Advances in Salivary Diagnostics

https://libcat.nshealth.ca/en/permalink/provcat39442
Charles F. Streckfus, editor. --Berlin, Heidelberg: Springer , c2015.
Available Online
View e-Book
Location
Online
This book reviews the progress made in salivary diagnostics and identifies the likely direction of future endeavors. After an introductory section describing the histological and anatomical features of the salivary glands and salivary function, salivary collection devices and diagnostic platforms are reviewed. The field of "salivaomics" is then considered in detail, covering, for example, proteomics, the peptidome, DNA and RNA analysis, biomarkers, and methods for biomarker discovery. Salivary …
Available Online
View e-Book
Other Authors
Streckfus, Charles F
Responsibility
Charles F. Streckfus, editor
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xiii, 204 p. : 48 illus., 38 illus. in color)
ISBN
9783662453995
9783662453988 (print ed.)
Subjects (MeSH)
Biomarkers
Clinical Chemistry Tests
Pathologic Processes - diagnosis
Saliva - physiology
Salivary Glands
Abstract
This book reviews the progress made in salivary diagnostics and identifies the likely direction of future endeavors. After an introductory section describing the histological and anatomical features of the salivary glands and salivary function, salivary collection devices and diagnostic platforms are reviewed. The field of "salivaomics" is then considered in detail, covering, for example, proteomics, the peptidome, DNA and RNA analysis, biomarkers, and methods for biomarker discovery. Salivary diagnostics for oral and systemic diseases are thoroughly discussed, and the role of salivary gland tissue engineering for future diagnostics is explored. The book closes by considering legal issues and barriers to salivary diagnostic development. Advances in Salivary Diagnostics will be an informative and stimulating reference for both practitioners and students.
Contents
1 Introduction -- 2 The History of Salivary Diagnostics -- 3 Saliva Collection Devices and Diagnostic Platforms -- 4 Salivary Omics -- 5 Salivary Diagnostics and the Oral Microbiome -- 6 Development of Nanoparticle- Enabled Protein Biomarker Discovery: Implementation for Saliva-Based Traumatic Brain Injury Detection -- 7 Saliva Diagnostics for Oral Diseases -- 8 Salivary Gland Tissue Engineering and Future Diagnostics -- 9 Using Saliva Secretions to Model Disease Progression.
Format
e-Book
Location
Online
Less detail

Biomarkers for Endometriosis : State of the Art

https://libcat.nshealth.ca/en/permalink/provcat41842
Thomas D'Hooghe, editor. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
This book presents an overview of the diagnostic performance of non- or semi-invasive tests for endometriosis in peripheral blood, endometrium, saliva, peritoneal fluid and urine. The value of existing and emerging systems biology technologies for biomarker development is addressed in several chapters on genetics, microarrays, proteomics and metabolomics. Although tests with high sensitivity and acceptable specificity have been developed, sometimes validated in independent populations and seem …
Available Online
View e-Book
Other Authors
D'Hooghe, Thomas
Responsibility
Thomas D'Hooghe, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (xii, 267 pages) : 8 illus., 3 illus. in color
ISBN
9783319598567
9783319598543 (print ed.)
Subjects (MeSH)
Biomarkers
Endometriosis - diagnosis
Abstract
This book presents an overview of the diagnostic performance of non- or semi-invasive tests for endometriosis in peripheral blood, endometrium, saliva, peritoneal fluid and urine. The value of existing and emerging systems biology technologies for biomarker development is addressed in several chapters on genetics, microarrays, proteomics and metabolomics. Although tests with high sensitivity and acceptable specificity have been developed, sometimes validated in independent populations and seem promising, more research is needed to translate these data into clinical benefit for patients and coordinate efforts internationally to standarize analysis, reports and operating procedures. The gold standard to diagnose endometriosis is currently through laparoscopic inspection with histological confirmation, a surgical procedure with rare but significant potential risks for the patients. A non-invasive test for endometriosis would be critical for the early detection of endometriosis of symptomatic women with pelvic pain and/or subfertility with normal ultrasound. This would include nearly all cases of minimal-mild endometriosis, some cases of moderate-severe endometriosis without a clearly visible ovarian endometrioma and cases with pelvic adhesions and/or other pelvic pathology, who might benefit from surgery to improve pelvic pain and/or subfertility. Such a test would also be useful in symptomatic women with ultrasound imaging suspicious for endometriosis, since it may be difficult to differentiate an ovarian endometrioma from other ovarian cysts and since the quality of ultrasound imaging is highly variable worldwide.
Contents
Building Translational Research Infrastructure and Access to Expertise for Biomarker Discovery in Cancer -- Biomarkers of Endometrial Cancer -- Biomarker Development in Chronic Inflammatory Diseases -- Endometriosis and Diagnostic Delay: The Patient’s Perspective -- Genetic Biomarkers for Endometriosis -- Epidemiological and Clinical Risk Factors for Endometriosis -- Peripheral Blood Biomarkers for Endometriosis -- Biomarkers for Endometriosis in Saliva, Urine, and Peritoneal Fluid -- mRNA and miRNA Biomarkers for Endometriosis -- Proteomic Biomarkers for Endometriosis -- Harmonization of Clinical and Laboratory Data to Improve Biomarker Discovery in Endometriosis: WERF EPHect -- OMICs Studies and Endometriosis Biomarker Identification.
Format
e-Book
Location
Online
Less detail

Biomarkers in Cancer Therapy : Liquid Biopsy Comes of Age

https://libcat.nshealth.ca/en/permalink/provcat44460
Hideaki Shimada, editor. --Singapore: Springer , 2019.
Available Online
View e-Book
Location
Online
This book sheds new light on research into liquid biopsy biomarkers for cancer screening. The chapters in the first half address exosomes, circulating cell-free DNA and autoantibodies, and main solid cancers, along with companion biomarkers – all of which serve as the basis for exploring key research questions for future clinical trials in the book’s second half. The study of biomarkers has evolved rapidly thanks to advances in precision medicine. While conventional cancer biomarker research is…
Available Online
View e-Book
Other Authors
Shimada, Hideaki
Responsibility
Hideaki Shimada, editor
Place of Publication
Singapore
Publisher
Springer
Date of Publication
2019
Physical Description
1 online resource (viii, 157 p.) : 22 illus., 17 illus. in color
ISBN
9789811372957
9789811372940 (Print ed.)
9789811372964 (Print ed.)
9789811372971 (Print ed.)
Subjects (MeSH)
Biomarkers
Liquid Biopsy
Neoplasms - diagnosis
Specialty
Clinical Laboratory Techniques
Medical Oncology
Abstract
This book sheds new light on research into liquid biopsy biomarkers for cancer screening. The chapters in the first half address exosomes, circulating cell-free DNA and autoantibodies, and main solid cancers, along with companion biomarkers – all of which serve as the basis for exploring key research questions for future clinical trials in the book’s second half. The study of biomarkers has evolved rapidly thanks to advances in precision medicine. While conventional cancer biomarker research is focused on proteomics or gene analysis of resected tissue, diagnostic markers have since become significant in terms of gauging the effectiveness of molecularly targeted drugs or the likelihood of a favorable prognosis. In addition, conventional treatment strategy, which draws on archives of resected tissue samples, is now gradually being replaced by monitoring with the use of liquid biopsy, which is poised to become the new mainstream in molecular targeting therapy. The contributing authors discuss in detail biomarkers, molecular targets for treatment, monitoring markers to evaluate treatment responses, prognostic markers, and screening and early diagnosis. Accordingly, this excellent collection of texts will benefit not only oncologists, but also medical and biological researchers and pharmaceutical scientists involved in the latest cancer research.
Contents
Part I. Various Strategies to Detect Cancer -- 1. Liquid Biopsy Diagnostics Using Extracellular Vesicles -- 2. Cell-Free DNA -- 3. Autoantibody in Cancer -- 4. Serum Angiogenic Factors as Cancer Biomarkers -- 5. Biomarkers of Cancer Stem Cells in Cancer Therapy -- Part II. Biomarkers for Individual Cancers -- 6. Specifics 1: Head and Neck Cancer and Esophageal Cancer -- 7. Biomarkers in Gastric Cancer -- 8. Liquid Biopsy in Hepatocellular Carcinoma -- 9. Biomarkers of Pancreatic Cancer -- 10. Biomarkers of Lung Cancer: Liquid Biopsy Comes of Age -- 11. Biomarkers for Breast Cancer Treatment -- 12. Biomarkers of Prostate Cancer -- 13. Biomarkers of Gynecological Cancers -- 14. Biomarkers of Malignant Pleural Mesothelioma.
Format
e-Book
Location
Online
Less detail

Biomarkers in Inflammatory Bowel Diseases

https://libcat.nshealth.ca/en/permalink/provcat44481
Nik Sheng Ding, Peter De Cruz, editors. --Cham: Springer , c2019.
Available Online
View e-Book
Location
Online
This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, p…
Available Online
View e-Book
Other Authors
Sheng Ding, Nik
De Cruz, Peter
Responsibility
Nik Sheng Ding, Peter De Cruz, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2019
Physical Description
1 online resource (xvii, 365 p.) : 35 illus., 30 illus. in color
ISBN
9783030114466
9783030114459 (Print ed.)
9783030114473 (Print ed.)
Subjects (MeSH)
Biomarkers
Inflammatory Bowel Diseases - diagnosis
Specialty
Clinical Laboratory Techniques
Gastroenterology
Abstract
This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.
Contents
1. Introduction -- Part I. Background to Biomarkers -- 2. Clinical Risk Factors: Lessons from Epidemiology -- 3. Disease Modification in Crohn’s Disease -- 4. Personalized Medicine - Dream or Reality? -- 5. Clinical Trial Design to Facilitate Biomarker Discovery -- Part II. Clinical Algorithms Incorporating Predictive and Prognostic Biomarkers: Crohn’s Disease -- 6. Luminal Crohn’s Disease -- 7. Fibrosis and Stricturing Disease in Crohn’s Disease -- 8. Postoperative Crohn’s Disease -- 9. Perianal Crohn’s Disease -- Part III. Clinical Algorithms Incorporating Predictive and Prognostic Biomarkers: Ulcerative Colitis -- 10. Biomarkers in Acute Severe Ulcerative Colitis -- 11. Chronic Active Ulcerative Colitis -- 12. Refractory Proctitis -- 13. UC Surveillance -- 14. The Role of Biomarkers in the Ileal Anal Pouch -- Part IV. Clinical Algorithms Incorporating Predictive and Prognostic Biomarkers: Specialised Scenarios -- 15. Extra-intestinal Manifestations in Inflammatory Bowel Disease: Diagnosis and Management -- 16. Primary Sclerosing Cholangitis Overlapping with IBD -- 17. Pregnancy and IBD -- 18. Nutrition in IBD -- 19. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Optimising Therapeutic Effectiveness of Thiopurines -- 20. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Optimising Therapeutic Effectiveness of Biologics -- 21. Drug Toxicity: Personalising IBD Therapeutics–The Use of Genetic Biomarkers to Reduce Drug Toxicity -- 22. Biomarkers for Remote Monitoring -- Part V. Scientific Platforms for Biomarker Discovery -- 23. Exposome and Diet -- 24. The Microbiome in IBD -- 25. Metabolic Profiling in IBD -- 26. Innate and Adaptive Immunology -- 27. Genetic and Genomic Markers for Prognostication -- 28. Risk Alleles for Drug Targets: Genomic Markers of Drug Response -- Part VI. Conclusion -- 29. Big Data Meets Real World! The Use of Clinical Informatics in Biomarker Research -- 30. Bringing It Altogether: A Systems Biology Approach to Biomarkers in Inflammatory Bowel Disease.
Format
e-Book
Location
Online
Less detail

Biomarkers in Periodontal Health and Disease : Rationale, Benefits, and Future Directions

https://libcat.nshealth.ca/en/permalink/provcat44899
Nurcan Buduneli. --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
This book examines all aspects of the progress being made towards the development of highly specific and sensitive biomarkers that will overcome the shortcomings of clinical assessments in periodontics. The opening chapters present the basic anatomic features of periodontal tissues, outline the nature and pathogenic mechanisms of periodontal diseases, and discuss both conventional and novel methods of diagnosis with reference to their specificity and sensitivity. The potential role of biomarker…
Available Online
View e-Book
Author
Buduneli, Nurcan
Responsibility
Nurcan Buduneli
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (xv, 90 p.) : 34 illus., 33 illus. in color
ISBN
9783030373177
9783030373153 (Print ed.)
9783030373160 (Print ed.)
Subjects (MeSH)
Biomarkers
Periodontal Diseases - diagnosis
Specialty
Dentistry
Diagnosis
Oral Health
Abstract
This book examines all aspects of the progress being made towards the development of highly specific and sensitive biomarkers that will overcome the shortcomings of clinical assessments in periodontics. The opening chapters present the basic anatomic features of periodontal tissues, outline the nature and pathogenic mechanisms of periodontal diseases, and discuss both conventional and novel methods of diagnosis with reference to their specificity and sensitivity. The potential role of biomarkers in periodontal diagnosis is then presented in the light of the published data. The biological samples in which potential biomarkers are sought are evaluated comparatively, drawing attention to their strengths and weaknesses, and the available technologies for biomarker studies are reviewed. The potential benefits of biomarkers are also discussed with regard to the possible bidirectional interactions between periodontal diseases and systemic health. Finally, the past, present, and future of periodontics are examined from a broader perspective. Readers will find the book to be an ideal summary of the state of the art in the field as biomarkers emerge that promise to facilitate periodontal diagnostics and permit timely, personally tailored interventions.
Contents
1. Anatomy of Periodontal Tissues -- 2. Nature of Periodontal Diseases -- 3. Conventional Diagnosis of Periodontal Diseases and 2017 Classification System -- 4. Novel Diagnostic Approaches in Periodontics -- 5. Biomarkers for Periodontal Diseases -- 6. Biological Samples for Biomarkers: Strengths and Weaknesses -- 7. Technologies for Biomarkers in Periodontics -- 8. Biomarkers in Periodontal Disease and Systemic Health Intersection -- 9. Past, Present and Future of Periodontics.
Format
e-Book
Location
Online
Less detail

Biomarkers of Cardiometabolic Risk, Inflammation and Disease

https://libcat.nshealth.ca/en/permalink/provcat39237
Filipe Palavra, Fl©vio Reis, Daniela Marado, Armando Sena, editors. --Cham: Springer , c2015.
Available Online
View e-Book
Location
Online
This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders. Biomarkers of Cardiometabolic Ris…
Available Online
View e-Book
Other Authors
Palavra, Filipe
Reis, Fl©vio
Marado, Daniela
Sena, Armando
Responsibility
Filipe Palavra, Fl©vio Reis, Daniela Marado, Armando Sena, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (x, 165 p. : 11 illus. in color)
ISBN
9783319160184
9783319160177 (print ed.)
Subjects (MeSH)
Biomarkers
Cardiovascular Diseases - diagnosis
Inflammation
Risk Factors
Abstract
This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders. Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors, and clinical and basic researchers working on cardiovascular and autoimmune disorders.
Contents
Inflammation biomarkers and cardiometabolic risk -- Cardiovascular disease -- Diabetes mellitus and metabolic syndrome -- Ischemic stroke -- Chronic kidney disease -- Immune-mediated inflammatory rheumatic diseases -- Cardiometabolic risk, inflammation and neurodegenerative disorders.
Format
e-Book
Location
Online
Less detail

Biomarkers of kidney disease

https://libcat.nshealth.ca/en/permalink/provcat31569
edited by Charles L. Edelstein. (2nd ed.) --Amsterdam, Netherlands: Elsevier , c2017.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Available Online
View e-Book
Other Authors
Edelstein, Charles L
Responsibility
edited by Charles L. Edelstein
Edition
2nd ed.
Place of Publication
Amsterdam, Netherlands
Publisher
Elsevier
Date of Publication
c2017
Physical Description
1 online resource
ISBN
9780128030141
Subjects (MeSH)
Kidney Diseases - diagnosis
Biological Markers
Subjects (LCSH)
Kidney Diseases - diagnosis
Biological Markers
Kidneys - Diseases - Molecular diagnosis
Biochemical markers
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Cardiac Biomarkers : Case Studies and Clinical Correlations

https://libcat.nshealth.ca/en/permalink/provcat40319
Alan S. Maisel, Allan S. Jaffe, editors. --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book presents a comprehensive compendium of case studies to inform clinicians how to optimally deploy the major clinically utilized biomarkers in cardiology. Biomarkers now play an integral role in the treatment and management of patients with congestive heart failure and acute ischemic heart disease because they provide crucial information about the status of individual patients. For that reason, it is important for clinicians to understand the basis for the use of these markers. Every re…
Available Online
View e-Book
Other Authors
Maisel, Alan S
Jaffe, Allan S
Responsibility
Alan S. Maisel, Allan S. Jaffe, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xviii, 370 p. : 56 illus., 40 illus. in color)
ISBN
9783319429823
9783319429809 (print ed.)
Subjects (MeSH)
Biomarkers
Heart Failure
Myocardial Ischemia
Natriuretic Peptides - therapeutic use
Troponin - therapeutic use
Abstract
This book presents a comprehensive compendium of case studies to inform clinicians how to optimally deploy the major clinically utilized biomarkers in cardiology. Biomarkers now play an integral role in the treatment and management of patients with congestive heart failure and acute ischemic heart disease because they provide crucial information about the status of individual patients. For that reason, it is important for clinicians to understand the basis for the use of these markers. Every reader may not have the laboratory and/or clinical expertise to understand all the details associated with the use of these markers, which is why this book takes a case oriented approach and by doing so provides a practical resource to guide the clinician through the options available. Cardiac Biomarkers discusses how to use these biomarkers optimally and, in particular, how to understand when values provide actionable information. The book an essential guide for all physicians and healthcare practitioners in the field of cardiology.
Contents
[publisher supplied] The patient with chest pain: The troponin story -- Troponin Basics for the clinician -- Pathophysiology of trop I and T in myocardial ischemia/infarction -- International Definition of MI- rationale and practice -- Evaluation of patients presenting with chest pain- where do troponins fit in -- Using contemporary troponin in patients with AMI -- Using troponins to guide therapy in ACS -- Use of cTn in patients with heart failure -- Elevated cTn in other acute situations -- Use of cTn for detection of more chronic disease states -- High sensitivity assays- what are they and why do we need them -- Use of troponin for the evaluation of patients potentially at risk for cardiovascular disease -- Gaps in our biomarker armamentarium: what novel biomarkers might be synergistic in patients with acute disease -- The patient with shortness of breath: the natriuretic peptide story -- Evaluation of patients presenting with sob- where do nps fit in -- Pathophysiology of bnp, and ntpro bnp -- A clinicians guide to lab assays for nps -- Using NPS in the ED- diagnosis -- Using NPs in the ED- algorithms and risk stratification -- Using NPs in the hospital -- NPs at the time of discharge -- Finger stick NP levels at home -- Guiding therapy of heart failure with NPs -- Caveats to NP measurement -- Other biomarkers for heart failure -- Biomarkers of cardiorenal disease -- Biomarkers of cardiac risk.
Format
e-Book
Publication Type
Case Reports
Location
Online
Less detail

Damage-Associated Molecular Patterns in Human Diseases : Volume 2: Danger Signals as Diagnostics, Prognostics, and Therapeutic Targets

https://libcat.nshealth.ca/en/permalink/provcat45638
Walter Gottlieb Land. --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
This book is a continuance of the topic: “DAMPs in Human Diseases”, the basics of which were described in a first volume by the same author. This second volume presents our current understanding of the impact of sterile stress/injury-induced innate immune responses on the etiopathogenesis of human diseases by focusing on those diseases that are pathogenetically dominated by DAMPs, i.e., on polytrauma, various solid organ injuries (brain, lung, kidney, liver), atherosclerosis, and cerebro-cardio…
Available Online
View e-Book
Author
Land, Walter Gottlieb
Responsibility
Walter Gottlieb Land
Alternate Title
Danger signals as diagnostics, prognostics, and therapeutic targets
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (xxxix, 629 p.) : 45 illus. in color
ISBN
9783030538682
9783030538675 (Print ed.)
9783030538699 (Print ed.)
9783030538705 (Print ed.)
Subjects (MeSH)
Biomarkers
Immunologic Techniques
Molecular Medicine
Pathogen-Associated Molecular Pattern Molecules
Stress, Physiological - immunology
Wounds and Injuries - immunology
Specialty
Diagnosis
Molecular Medicine
Pathology
Abstract
This book is a continuance of the topic: “DAMPs in Human Diseases”, the basics of which were described in a first volume by the same author. This second volume presents our current understanding of the impact of sterile stress/injury-induced innate immune responses on the etiopathogenesis of human diseases by focusing on those diseases that are pathogenetically dominated by DAMPs, i.e., on polytrauma, various solid organ injuries (brain, lung, kidney, liver), atherosclerosis, and cerebro-cardiovascular diseases. Our growing understanding of the pathogenetic function of activating DAMPs and suppressive DAMPs (“SAMPs”) is used as a point of departure to explore how these molecules can be used as biomarkers to extend and improve current diagnostic and prognostic modalities. Moreover, this new knowledge about the pathogenetic function of DAMPs and SAMPs is taken as a sound and plausible reason for discussing their implications for present and future treatment of the diseases addressed here. In this context, the focus is on the potential of DAMPs as future therapeutic targets and SAMPs as future therapeutics, applied in strict compliance with safety precautions, as also recommended in this work. The book is intended for professionals from all medical and paramedical disciplines who are interested in applying innovative data from inflammation and immunity research to clinical practice. The readership will include practitioners and clinicians working in the broad field of acute and chronic inflammatory/fibrotic diseases, in particular, traumatologists and intensivists; neurologists and neurosurgeons; cardiologists and cardiac surgeons; pulmonologists and thoracic surgeons; vascular surgeons; nephrologists; gastroenterologists and hepatologists; and pharmacists. Also available: Damage-Associated Molecular Patterns in Human Diseases, Vol. 1: Injury-Induced Innate Immune Responses.
Contents
Part I. Prologue -- Perspectives of the Danger/Injury Model in Immunology -- Part II. A Select, Clinically Oriented Update of Topics Presented in “Damage-Associated Molecular Patterns in Human Diseases, Volume 1: Injury-Induced Innate Immune Responses" -- Pattern Recognition Molecules -- The Growing World of DAMPs -- The Growing Clinical Relevance of Cellular Stress Responses and Regulated Cell Death -- DAMP-Promoted Efferent Innate Immune Responses in Human Diseases: Inflammation -- DAMP-Promoted Efferent Innate Immune Responses in Human Diseases: Fibrosis -- Part III. DAMPs and SAMPs in Traumatic Disorders, Atherosclerosis, and Cerebro-Cardiovascular Diseases -- DAMPs and SAMPs as Molecular Biomarkers, Therapeutic Targets, and Therapeutics -- DAMP-Controlled and Uncontrolled Responses to Trauma: Wound Healing and Polytrauma -- Solid Organ Injury -- Atherosclerosis -- Cerebro - Cardiovascular Diseases -- Part IV. Epilogue -- The “DAMPome” as a Key Player in the Pathogenesis of Human Diseases.
Format
e-Book
Location
Online
Less detail

Diagnosis of Blood and Bone Marrow Disorders

https://libcat.nshealth.ca/en/permalink/provcat42790
Sa A. Wang, Robert P. Hasserjian, editors. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
This book focuses on hematopoietic and lymphoid neoplasms that initially present as peripheral blood abnormalities, with either cytopenias or elevated peripheral blood counts, as well as non-neoplastic conditions that may raise concern for a hematologic malignancy. The scope of the book includes myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPN), as well as lymphomas and lymphoid leukemias that typically present init…
Available Online
View e-Book
Other Authors
Wang, Sa A.
Hasserjian, Robert P.
Responsibility
Sa A. Wang, Robert P. Hasserjian, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (ix, 412 p.) : 218 illus., 217 illus. in color
ISBN
9783319202792
9783319202785 (print ed.)
9783319202808 (print ed.)
Subjects (MeSH)
Biomarkers
Bone Marrow Diseases - diagnosis
Hematologic Diseases - diagnosis
Hematologic Neoplasms - diagnosis
Hematopoietic Stem Cells
Specialty
Hematology
Abstract
This book focuses on hematopoietic and lymphoid neoplasms that initially present as peripheral blood abnormalities, with either cytopenias or elevated peripheral blood counts, as well as non-neoplastic conditions that may raise concern for a hematologic malignancy. The scope of the book includes myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPN), as well as lymphomas and lymphoid leukemias that typically present initially with peripheral blood abnormalities. Within each category, a comprehensive list of differential diagnoses is discussed. For each disease entity, the reader is updated with new molecular genetic data, biomarkers, and recent applications of immunophenotyping, and how to incorporate the new information in disease diagnosis and classifications is illustrated, including the use of diagnostic algorithms where appropriate. The book employs the revised WHO Classification of Hematopoietic Neoplasms for all disease entities. Diagnosis of Blood and Bone Marrow Disorders will serve as a very useful resource for pathologists, pathologists in training, hematologists and medical technologists who are involved in the clinical work-up of patients with bone marrow and blood neoplasms. It will provide a practical and concise yet comprehensive review.
Contents
1. Identifying Blood and Bone Marrow Abnormalities in the Laboratory -- 2. Cytopenias: Reactive and Neoplastic -- 3. Inherited Bone Marrow Failure Syndromes, Myeloid Neoplasms with Germline Predisposition and Myeloid Proliferations Associated with Down Syndrome -- 4. Cytopenias: Acquired Bone Marrow Failure -- 5. Leukocytosis: Neutrophilia, Basophilia, and Blasts -- 6. Leukocytosis: Eosinophilia -- 7. Monocytosis -- 8. Thrombocytosis -- 9. Erythrocytosis -- 10. Mixed Cytoses and Cytopenias -- 11. T- and NK-Cell Lymphocytosis -- 12. B-Cell Lymphocytosis -- 13. Multiple Myeloma and Other Plasma Cell Neoplasms.
Format
e-Book
Location
Online
Less detail

Gastric Cancer In The Precision Medicine Era : Diagnosis and Therapy

https://libcat.nshealth.ca/en/permalink/provcat44285
Vincenzo Canzonieri, Antonio Giordano, editors. --Cham: Humana Press , 2019.
Available Online
View e-Book
Location
Online
This book provides a comprehensive, state-of-the art review and serves as an overview of the different aspects of gastric cancer. The first section aims to clarify the main aspects of tumorigenesis, such as the role of inflammation linked to the presence of H. Pylori infection, and the genetic and epigenetic mechanisms so far known. Secondly, an exhaustive overview of the diagnosis of gastric cancer from a clinical/endoscopic and pathologic perspective will be illustrated. The second section in…
Available Online
View e-Book
Other Authors
Canzonieri, Vincenzo
Giordano, Antonio
Responsibility
Vincenzo Canzonieri, Antonio Giordano, editors
Place of Publication
Cham
Publisher
Humana Press
Date of Publication
2019
Physical Description
1 online resource (xv, 256 p.: 47 illus. in color
Series
Current Clinical Pathology
Series Title
Current clinical pathology
ISBN
9783030048617
9783030048600 (Print ed.)
9783030048624 (Print ed.)
ISSN
2197-781X
Subjects (MeSH)
Biomarkers
Precision Medicine
Stomach Neoplasms - diagnosis
Stomach Neoplasms - therapy
Specialty
Gastroenterology
Medical Oncology
Precision Medicine
Abstract
This book provides a comprehensive, state-of-the art review and serves as an overview of the different aspects of gastric cancer. The first section aims to clarify the main aspects of tumorigenesis, such as the role of inflammation linked to the presence of H. Pylori infection, and the genetic and epigenetic mechanisms so far known. Secondly, an exhaustive overview of the diagnosis of gastric cancer from a clinical/endoscopic and pathologic perspective will be illustrated. The second section includes the pathological and clinical features and contains information regarding the most recent tissue and serological biomarkers in these neoplasms. The three successive sections are intended to provide the “state of art” of multimodal treatment approaches to gastric cancer, i.e. standard and novel surgical aspects, common and innovative chemo and radio protocols and modern targeted therapies. Novel molecular classifications are under consideration to improve diagnostic and prognostic definitions and to prospect future treatments based on the use of immunotherapies and innovative molecules such as non-coding RNA and nanoparticles. Gastric Cancer in the Precision Medicine Era serves as a useful resource for physicians and researchers dealing with, and interested in, this challenging malignancy. It provides a concise yet comprehensive summary of the current status of the field that helps guide patient management and stimulates investigative efforts. All chapters are written by experts in their fields and includes the most up to date scientific and clinical information.
Contents
Part I. Gastric Tumorigenesis -- Gastric Tumorigenesis: Role of Inflammation and Helicobacter Pylori -- Genetic and Epigenetic Mechanisms in Gastric Cancer -- Part II. Clinical and Pathological Characteristics -- Diagnosis and Surveillance: Endoscopic Hallmarks -- Pathological Diagnosis And Classification Of Gastric Epithelial Tumors -- Diagnostic, Prognostic, Predictive and Therapeutic Tissue Biomarkers in Gastric Cancer -- Serum Biomarkers in Gastric Cancer -- Part III. Gastric Cancer Therapy: Multimodal Treatment Approach -- New Agents in the Treatment of Advanced Gastric Cancer: Targeted Therapy and Immunotherapy -- Combined-Modality Treatment for Locally Advanced Gastric Cancer: Current Evidences and New Perspectives -- Surgical Strategies in Gastric Cancer -- Part IV. Evolving Treatment Landscape in Gastric Cancer -- From Molecular Classification to Targeted Therapy for Gastric Cancer in the Precision Medicine Era -- Part V. Future Medicine in Gastric Cancer -- Non-Coding RNA in Gastric Cancer with Potential Prognostic and Predictive Role -- Immunomodulation and Immunotherapy for Gastric Cancer -- Nanomedicine in Gastric Cancer.
Format
e-Book
Location
Online
Less detail

Imaging Biomarkers : Development and Clinical Integration

https://libcat.nshealth.ca/en/permalink/provcat41481
Luis Martí-Bonmatí, Angel Alberich-Bayarri, editors. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
This is the first book to cover all aspects of the development of imaging biomarkers and their integration into clinical practice, from the conceptual basis through to the technical aspects that need to be considered in order to ensure that medical imaging can serve as a powerful quantification instrument capable of providing valuable information on organ and tissue properties. The process of imaging biomarker development is considered step by step, covering proof of concept, proof of mechanism…
Available Online
View e-Book
Other Authors
Martí-Bonmatí, Luis
Alberich-Bayarri, Angel
Responsibility
Luis Martí-Bonmatí, Angel Alberich-Bayarri, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (viii, 316 pages) : 104 illus., 75 illus. in color
ISBN
9783319435046
9783319435022 (print ed.)
Subjects (MeSH)
Biomarkers
Diagnostic Imaging - methods
Image Interpretation, Computer-Assisted
Abstract
This is the first book to cover all aspects of the development of imaging biomarkers and their integration into clinical practice, from the conceptual basis through to the technical aspects that need to be considered in order to ensure that medical imaging can serve as a powerful quantification instrument capable of providing valuable information on organ and tissue properties. The process of imaging biomarker development is considered step by step, covering proof of concept, proof of mechanism, image acquisition, image preparation, imaging biomarker analysis and measurement, detection of measurement biases (proof of principle), proof of efficacy and effectiveness, and reporting of results. Sources of uncertainty in the accuracy and precision of measurements and pearls and pitfalls in gold standards and biological correlation are discussed. In addition, practical use cases are included on imaging biomarker implementation in brain, oncologic, cardiovascular, musculoskeletal, and abdominal diseases. The authors are a multidisciplinary team of expert radiologists and engineers, and the book will be of value to all with an interest in the quantitative imaging of biomarkers in personalized medicine.
Contents
1. The Shift in Paradigm to Precision Medicine in Imaging: International Initiatives for the Promotion of Imaging Biomarkers -- 2. Introduction to the Stepwise Development of Imaging Biomarkers -- 3. Defining the Biological Basis and Clinical Question (Proof of Concept); Looking for the Interrelationship (Proof of Mechanism) -- 4. Image Acquisition: Modality and Protocol Definition -- 5. MRI Preprocessing -- 6. Imaging Biomarker Structural Analysis -- 7. Imaging Biomarker Model-Based Analysis -- 8. Imaging Biomarker Measurements -- 9. Detecting Measurement Biases: Sources of Uncertainty, Accuracy, and Precision of the Measurements -- 10. Validating the Imaging Biomarker: The Proof of Efficacy and Effectiveness -- 11. The Final Step: Imaging Biomarkers in Structured Reports -- 12. Pearls and Pitfalls in Gold Standards and Biological Correlation -- 13. Imaging Biobanks, Big Data, and Population-Based Imaging Biomarkers -- 14. A Proposed Imaging Biomarkers Analysis Platform Architecture for Integration in Clinics -- 15. Use Case I: Imaging Biomarkers in Neurological Disease. Focus on Multiple Sclerosis -- 16. Use Case II: Imaging Biomarkers and New Trends for Integrated Glioblastoma Management -- 17. Use Case III: Imaging Biomarkers in Breast Tumours. Development and Clinical Integration -- 18. Use Case IV: Imaging Biomarkers in Thorax and Heart -- 19. Use Case V: Imaging Biomarkers in Musculoskeletal Disorders -- 20. Use Case VI: Imaging Biomarkers in Diffuse Liver Disease. Quantification of Fat and Iron -- 21. Imaging Biomarkers in Clinical Trials.
Format
e-Book
Location
Online
Less detail

MicroRNAs and Other Non-Coding RNAs in Inflammation

https://libcat.nshealth.ca/en/permalink/provcat39169
Catherine M. Greene, editor. --Cham: Springer , c2015.
Available Online
View e-Book
Location
Online
The book serves as a comprehensive resource for scientists and clinicians studying the role of non-coding RNAs in inflammation (viral infections, wound inflammation), human inflammatory diseases (i.e. rheumatoid arthritis, Crohn's disease, diabetes), and innate immunity. It provides a universal reference work comprising both basic and specialized information. Given that ncRNAs represent new therapeutic targets, this volume will also be of interest to industrial biomedical researchers and those …
Available Online
View e-Book
Other Authors
Greene, Catherine M
Responsibility
Catherine M. Greene, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (x, 237 p. : 17 illus., 16 illus. in color)
Series Title
Progress in inflammation research
ISBN
9783319136899
9783319136882 (print ed.)
Subjects (MeSH)
Biomarkers
Inflammation - genetics
MicroRNAs - genetics
RNA, Long Noncoding - genetics
Abstract
The book serves as a comprehensive resource for scientists and clinicians studying the role of non-coding RNAs in inflammation (viral infections, wound inflammation), human inflammatory diseases (i.e. rheumatoid arthritis, Crohn's disease, diabetes), and innate immunity. It provides a universal reference work comprising both basic and specialized information. Given that ncRNAs represent new therapeutic targets, this volume will also be of interest to industrial biomedical researchers and those involved in drug development.
Contents
The biology of microRNA -- The biology of long non-coding RNA -- microRNA regulation of neutrophil function -- How non-coding RNAs contribute to macrophage polarization -- Endogenous control of dendritic cell activation by miRNA -- Noncoding RNA expression during viral infection: the long and the short of it -- Wound inflammation: emerging role of miRNA -- The importance of microRNAs in rheumatoid arthritis -- MicroRNAs with impact on adipose tissue inflammation in obesity -- The relationship between miR-29, NOD2 and Crohn's disease -- The role of ncRNA in diabetes -- ncRNA as diagnostics and prognostics for hepatocellular carcinoma.
Format
e-Book
Location
Online
Less detail

Murine Models, Energy Balance, and Cancer

https://libcat.nshealth.ca/en/permalink/provcat39257
Nathan A. Berger, editor. --Cham: Springer , c2015.
Available Online
View e-Book
Location
Online
This volume provides a transdisciplinary and translational review of many of the leading murine models used to study the mechanisms, mediators and biomarkers linking energy balance to cancer. It provides a review of murine models that should be of interest to basic, clinical and applied research investigators as well as nutrition scientists and students that work in cancer prevention, cancer control and treatment. The worldwide obesity pandemic has been extensively studied by epidemiologic and …
Available Online
View e-Book
Other Authors
Berger, Nathan A
Responsibility
Nathan A. Berger, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xv, 295 p. : 40 illus., 36 illus. in color)
Series Vol.
10
Series Title
Energy balance and cancer
ISBN
9783319167336
9783319167329 (print ed.)
ISSN
2199-2622
Subjects (MeSH)
Biomarkers
Disease Models, Animal
Energy metabolism
Mice
Neoplasms - etiology
Obesity - complications
Abstract
This volume provides a transdisciplinary and translational review of many of the leading murine models used to study the mechanisms, mediators and biomarkers linking energy balance to cancer. It provides a review of murine models that should be of interest to basic, clinical and applied research investigators as well as nutrition scientists and students that work in cancer prevention, cancer control and treatment. The worldwide obesity pandemic has been extensively studied by epidemiologic and observational studies and even, in some cases, by randomized controlled trials. However, the development and control of obesity, its comorbidities and its impact on cancer usually occurs over such long periods that it is difficult, if not impossible to conduct randomized controlled trials in humans to investigate environmental contributions to obesity, energy balance and their impact on cancer. In contrast, model organisms, especially mice and rats, provide valuable assets for performing these studies under rigorously controlled conditions and in sufficient numbers to provide statistically significant results. In this volume, many of the leading and new murine models used to study the mechanisms and mediators linking cancer with obesity, sleep, exercise, their modification by environment and how they may continue to be used to further elucidate these relations as well as to explore preclinical aspects of prevention and/or therapeutic intervention are considered. This volume provides an important compilation and analysis of major experimental systems and principles for further preclinical research with translational impact on energy balance and cancer.
Contents
Relevance of Circadian Rhythm in Cancer -- Environmental Manipulation and Neuropeptide Effects on Energy Balance and Cancer -- The MRL Mouse: A Model of Regeneration and Cancer -- Living Large: What Mouse Models Reveal about Growth Hormone and Obesity -- Mouse Models to Study Obesity Effects on Hematologic Malignancies -- Energy Balance, IGF-1 and Cancer: Causal Lessons from Genetically Engineered Mice -- Mouse Models to Study Leptin in Breast Cancer Stem Cells -- Mouse Models used to study the effects of Diabetes, Insulin and IGFs on cancer -- Impact of Energy Balance on Chemically Induced Mammary Carcinogenesis in a Rat -- Models and Mechanisms of High Fat Diet Promotion of Pancreatic Cancer -- Maternal energetics and the developmental origins of prostate cancer in offspring -- Mouse Models to Study the Effect of Natural Products on Obesity-Associated NAFLD/NASH -- Mouse Models to Study Metformin Effects in Carcinogenesis.
Format
e-Book
Location
Online
Less detail

Orofacial Pain Biomarkers

https://libcat.nshealth.ca/en/permalink/provcat41900
Jean-Paul Goulet, Ana Miriam Velly, editors. --Berlin, Heidelberg: Springer , 2017.
Available Online
View e-Book
Location
Online
This book provides up-to-date information on all aspects of orofacial pain biomarkers. It opens by presenting background information on clinical phenotypes and the neurobiological substrates underlying chronic orofacial pain and by explaining the potential role of biomarkers in the diagnosis, prognostic evaluation, and treatment of orofacial pain. The main section of the book examines the contribution of human and animal studies to the field of biomarkers for orofacial pain and discusses biomar…
Available Online
View e-Book
Other Authors
Goulet, Jean-Paul
Velly, Ana Miriam
Responsibility
Jean-Paul Goulet, Ana Miriam Velly, editors
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (x, 155 pages) : 9 illus. in color
ISBN
9783662539941
9783662539927 (print ed.)
Subjects (MeSH)
Biomarkers
Facial Pain
Abstract
This book provides up-to-date information on all aspects of orofacial pain biomarkers. It opens by presenting background information on clinical phenotypes and the neurobiological substrates underlying chronic orofacial pain and by explaining the potential role of biomarkers in the diagnosis, prognostic evaluation, and treatment of orofacial pain. The main section of the book examines the contribution of human and animal studies to the field of biomarkers for orofacial pain and discusses biomarkers for masticatory muscle pain, temporomandibular joint pain, neuropathic face pain, and autonomic nervous system involvement in trigeminal facial pain. The potential impacts of the immune system on orofacial pain biomarkers and candidate gene phenotypes with possible links to chronic orofacial pain conditions are also addressed, and differences and similarities between saliva and serum biomarkers for pain are explained as well. The final section covers research-related issues in assessment methods and statistical analyses used in evaluating biomarkers, identifies future challenges and suggests new directions in the field.
Contents
Part I: Clinical and Epidemiological Aspects of Orofacial Pain -- 1. Orofacial Pain: Classification and Road Map to Clinical Phenotypes -- 2. Comorbidities in Individuals with Orofacial Pain and Their Impact on Biomarkers -- Part II: Mechanisms of Chronic Orofacial Pain -- 3. Neurobiological Mechanisms of Chronic Orofacial Pain -- 4. Oral and Craniofacial Pain: Contribution of Endogenous, Central Modulation Mechanisms -- Part III: Biomarkers in Orofacial Pain -- 5. Neurophysiologic Markers of Neuropathic Orofacial Pain -- 6. Masticatory Muscle Pain Biomarkers -- 7. Molecular Temporomandibular Joint Pain Biomarkers -- 8. Genetic Biomarkers of Orofacial Pain Disorders -- 9. Serum, Synovial, and Salivary Biomarkers for Orofacial Pain Conditions -- Part IV: Study Designs and Statistical Analysis for the Identification of Biomarkers, and Future Direction -- 10. Biomarkers in Epidemiologic Research: Definition, Classification, and Implication -- 11. Statistical Analysis in the Identification of Pain Biomarkers -- 12. Future Direction and Conclusion.
Format
e-Book
Location
Online
Less detail

Pan-cancer Integrative Molecular Portrait Towards a New Paradigm in Precision Medicine

https://libcat.nshealth.ca/en/permalink/provcat39380
Christophe Le Tourneau, Maud Kamal, editors. (1st ed.) --Cham: Springer , c2015.
Available Online
View e-Book
Location
Online
This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques, bioinformatics, high-throughput screening molecular techniques and the challenges entailed by implementing them in daily practice. It also covers the key role of pathology in the validation of molecu…
Available Online
View e-Book
Other Authors
Le Tourneau, Christophe
Kamal, Maud
Responsibility
Christophe Le Tourneau, Maud Kamal, editors
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (x, 144 p. : 100 illus., 50 illus. in color)
ISBN
9783319221892
9783319221885 (print ed.)
Subjects (MeSH)
Biomarkers
Clinical Trials as Topic
Neoplasms - genetics
Precision Medicine
Abstract
This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques, bioinformatics, high-throughput screening molecular techniques and the challenges entailed by implementing them in daily practice. It also covers the key role of pathology in the validation of molecular results and the complex assessment of predictive biomarkers. The different topics covered are supplemented by unique concrete examples based on the SHIVA trial. The authors are all members of the French Curie Institute, one of the world's foremost cancer research institutions.
Contents
Introduction: Rationale for Precision Medicine Clinical Trials -- The Key Role of Pathology in the Context of Precision Medicine Trials -- Basis for Molecular Genetics in Cancer -- Microarrays-Based Molecular Profiling to Identify Genomic Alterations -- High Throughput Technologies: DNA and RNA Sequencing Strategies and Potential -- Bioinformatics for Precision Medicine in Oncology -- Assessment of Biomarkers' Predictive Value of Efficacy -- Designs for Evaluating Precision Medicine Trials -- Conclusions and Perspectives: Challenges for the Clinical Implementation of Precision Medicine Trials.
Format
e-Book
Location
Online
Less detail

Post-Traumatic Arthritis : Pathogenesis, Diagnosis and Management

https://libcat.nshealth.ca/en/permalink/provcat38931
Steven A. Olson, MD, Farshid Guilak, PhD, editors. --Boston, MA: Springer US , c2015.
Available Online
View e-Book
Location
Online
Bringing together the most up-to-date research on post-traumatic arthritis (PTA) and its management, this book is a comprehensive presentation of the current thinking on all aspects of the mechanisms of joint injury and subsequent development of PTA. Divided into thematic sections, it includes discussions of the incidence and burden of PTA, both in society at large and in the military population specifically; the relevant experimental work on PTA, from basic science to animal models; peri-artic…
Available Online
View e-Book
Other Authors
Olson, MD, Steven A
Guilak, PhD, Farshid
Responsibility
Steven A. Olson, MD, Farshid Guilak, PhD, editors
Place of Publication
Boston, MA
Publisher
Springer US
Date of Publication
c2015
Physical Description
1 online resource (xx, 360 p. : 98 illus., 65 illus. in color)
ISBN
9781489976062
9781489976055 (print ed.)
Subjects (MeSH)
Biomarkers
Cartilage, Articular - pathology
Joint Deformities, Acquired - therapy
Osteoarthritis - diagnosis
Osteoarthritis - etiology
Osteoarthritis - therapy
Abstract
Bringing together the most up-to-date research on post-traumatic arthritis (PTA) and its management, this book is a comprehensive presentation of the current thinking on all aspects of the mechanisms of joint injury and subsequent development of PTA. Divided into thematic sections, it includes discussions of the incidence and burden of PTA, both in society at large and in the military population specifically; the relevant experimental work on PTA, from basic science to animal models; peri-articular tissue responses to joint injury and potential mechanisms of PTA; the current clinical assessment and treatment of common joint injuries leading to PTA; and emerging technologies and treatments for PTA, including biomarkers and stem cell therapies. Taken together, it will be an invaluable resource for orthopedic surgeons, rheumatologists and other joint injury researchers and clinicians.
Contents
Section I: The Problem of Post-Traumatic Arthritis -- Arthritis that Develops after Joint Injury: Is it Post-Traumatic Arthritis or Post-Traumatic OsteoArthritis? -- Post-Traumatic Arthritis: Definitions and Burden of Disease -- Arthritis after Joint Injury: The Military Experience -- Section II: Experimental Models of Joint Injury -- In Vitro Cartilage Explant Injury Models -- Animal Models of Meniscal Injury in Post-Traumatic Arthritis -- Anterior Cruciate Transection/Disruption Models of Posttraumatic Arthritis -- Closed Joint ACL Disruption Murine Model of PTA -- Whole Joint Models of Articular Injury and Articular Fracture -- Instability: Dynamic Loading Models -- Survey of Animal Models in Post-Traumatic Arthritis: Choosing the Right Model to Answer the Right Question -- Section III: Peri-articular Tissue Response to Joint Injury -- The Response of Cartilage to Injury -- The Response of the Subchondral Bone to Injury -- Genetic Variability in the Response to Injury -- Aging and Post-Traumatic Arthritis -- Potential Mechanisms of PTA: Cell Death -- Potential Mechanisms of PTOA: Inflammation -- Potential Mechanisms of PTA: Oxidative Stress -- Potential Mechanisms of PTA: Alterations in Joint Loading -- Section IV: Clinical Assessment and Treatment of Patients with Joint Injury -- Imaging Specific to Cartilage Injury -- Outcomes of ACL Injury: The MOON Consortium -- Current Treatment and Outcomes of Intra-articular Fractures -- Non-arthroplasty Treatments for PTA in the Lower Extremity -- Results of Arthroplasty in Post-Traumatic Arthritis -- Section V: Developing and Future Assessment and Therapies -- Measurement of Severity of Injury after Articular Fracture and Correlation with Post-Traumatic Arthritis Development -- Biomarkers of PTA -- Potential Targets for Pharmacologic Therapies for Prevention of PTA -- Stem Cell Therapies for Post-Traumatic Arthritis -- Unanswered Questions and Future Directions in Post-Traumatic Arthritis.
Format
e-Book
Location
Online
Less detail

Systemic lupus erythematosus

https://libcat.nshealth.ca/en/permalink/provcat51288
Tsokos, George C. (2nd ed.) --London, England: Academic Press , 2020.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Tsokos, George C.
Edition
2nd ed.
Place of Publication
London, England
Publisher
Academic Press
Date of Publication
2020
ISBN
9780128145517
Subjects (MeSH)
Biomarkers
Comorbidity
Lupus Erythematosus, Systemic - diagnosis
Lupus Erythematosus, Systemic - physiopathology
Lupus Erythematosus, Systemic - therapy
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail

Systemic lupus erythematosus : basic, applied and clinical aspects

https://libcat.nshealth.ca/en/permalink/provcat32189
edited by George C. Tsokos. (2nd ed.) --London, UK: Elsevier , c2021.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
This completely updated and expanded second edition of Systemic Lupus Erythematosus; Basic, Applied and Clinical Aspects includes topics not covered previously with contributors who are at the forefront of each specific topic and with a global appeal. Each chapter will be short and will be presented critically and not in an encyclopedic manner and with selected, up to 50, references which should be valuable to a wider audience. As a seasoned (not old) editor, he worked with practically all the…
Available Online
View e-Book
Other Authors
Tsokos, George C
Responsibility
edited by George C. Tsokos
Edition
2nd ed.
Place of Publication
London, UK
Publisher
Elsevier
Date of Publication
c2021
Physical Description
1 online resource, 694 p.
ISBN
9780128145517
Subjects (MeSH)
Biomarkers
Comorbidity
Lupus Erythematosus, Systemic - diagnosis
Lupus Erythematosus, Systemic - physiopathology
Lupus Erythematosus, Systemic - therapy
Subjects (LCSH)
Systemic lupus erythematosus
Lupus Erythematosus, Cutaneous
Lupus Erythematosus, Systemic
Antiphospholipid Syndrome
Specialty
Allergy and Immunology
Rheumatology
Abstract
This completely updated and expanded second edition of Systemic Lupus Erythematosus; Basic, Applied and Clinical Aspects includes topics not covered previously with contributors who are at the forefront of each specific topic and with a global appeal. Each chapter will be short and will be presented critically and not in an encyclopedic manner and with selected, up to 50, references which should be valuable to a wider audience. As a seasoned (not old) editor, he worked with practically all the contributors and this enables to achieve the goals of the book.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Therapeutic drug monitoring

https://libcat.nshealth.ca/en/permalink/provcat51315
Dasgupta, Amitava. (1st ed.) --Philadelphia, PA: Elsevier , 2012.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Dasgupta, Amitava
Edition
1st ed.
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
2012
ISBN
9780123854674
Subjects (MeSH)
Drug Monitoring
Biomarkers
Pharmacogenetics - methods
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail

23 records – page 1 of 2.